SMAD2 and Hepatic fibrosis: In vivo, TGF-β1/Smad2 signaling was up-regulated in the CCl4-induced hepatic fibrosis model, whereas PZH treatment curbed CCl4-induced high expression of TGF-β1 and p-Smad2.